CA2195665A1 - Pharmaceutical compositions comprising a chimaeric tnf binding protein - Google Patents
Pharmaceutical compositions comprising a chimaeric tnf binding proteinInfo
- Publication number
- CA2195665A1 CA2195665A1 CA002195665A CA2195665A CA2195665A1 CA 2195665 A1 CA2195665 A1 CA 2195665A1 CA 002195665 A CA002195665 A CA 002195665A CA 2195665 A CA2195665 A CA 2195665A CA 2195665 A1 CA2195665 A1 CA 2195665A1
- Authority
- CA
- Canada
- Prior art keywords
- tnf
- binding protein
- human
- tnf binding
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP94111455.5 | 1994-07-22 | ||
EP94111455 | 1994-07-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2195665A1 true CA2195665A1 (en) | 1996-02-08 |
Family
ID=8216138
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002195665A Abandoned CA2195665A1 (en) | 1994-07-22 | 1995-07-15 | Pharmaceutical compositions comprising a chimaeric tnf binding protein |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0772449A1 (cs) |
JP (1) | JPH09508140A (cs) |
AU (1) | AU3111995A (cs) |
BR (1) | BR9508419A (cs) |
CA (1) | CA2195665A1 (cs) |
CZ (1) | CZ283219B6 (cs) |
FI (1) | FI970247A0 (cs) |
HU (1) | HUT76666A (cs) |
NO (1) | NO970264L (cs) |
PL (1) | PL318501A1 (cs) |
WO (1) | WO1996003141A1 (cs) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6429290B1 (en) | 1994-08-17 | 2002-08-06 | The Rockefeller University | OB polypeptides, modified forms and derivatives |
US6350730B1 (en) | 1994-08-17 | 2002-02-26 | The Rockefeller University | OB polypeptides and modified forms as modulators of body weight |
US6471956B1 (en) | 1994-08-17 | 2002-10-29 | The Rockefeller University | Ob polypeptides, modified forms and compositions thereto |
US6001968A (en) | 1994-08-17 | 1999-12-14 | The Rockefeller University | OB polypeptides, modified forms and compositions |
US20030040467A1 (en) | 1998-06-15 | 2003-02-27 | Mary Ann Pelleymounter | Ig/ob fusions and uses thereof. |
US6936439B2 (en) | 1995-11-22 | 2005-08-30 | Amgen Inc. | OB fusion protein compositions and methods |
CA2253557A1 (en) * | 1996-05-08 | 1997-11-13 | Louis Martin Renzetti | Treatment of asthma with tnfr-ig |
TW555765B (en) * | 1996-07-09 | 2003-10-01 | Amgen Inc | Low molecular weight soluble tumor necrosis factor type-I and type-II proteins |
US7070771B1 (en) | 1996-12-09 | 2006-07-04 | Regents Of The University Of California | Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells |
CA2272822A1 (en) * | 1996-12-12 | 1998-06-18 | Genentech, Inc. | Hvem polypeptides and uses thereof |
AU769964B2 (en) | 1998-11-27 | 2004-02-12 | Synaptics (Uk) Limited | Position sensor |
PL374045A1 (en) | 2001-02-23 | 2005-09-19 | Immunex Corporation | Efficient recovery of correctly refolded proteins |
WO2003011323A1 (en) * | 2001-07-30 | 2003-02-13 | Genset S.A. | Agonists and antagonists of contabix for use in the treatment of metabolic disorders |
US7786282B2 (en) | 2001-12-06 | 2010-08-31 | The Regents Of The University Of California | Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain |
SI1471974T1 (sl) | 2002-02-06 | 2007-12-31 | Ares Trading Sa | Tumorje nekrotizirajoäśi faktor, kombiniran z interferonom, pri demielinizirajoäśih boleznih |
KR101370253B1 (ko) | 2004-10-22 | 2014-03-05 | 암젠 인크 | 재조합 항체의 재접힘 방법 |
JP2017525370A (ja) | 2014-08-21 | 2017-09-07 | ザ ジェネラル ホスピタル コーポレイション | 腫瘍壊死因子スーパーファミリーおよびtnf様リガンドムテインならびに腫瘍壊死因子スーパーファミリーおよびtnf様リガンドムテインを調製および使用する方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL98078A0 (en) * | 1991-05-07 | 1992-06-21 | Yeda Res & Dev | Pharmaceutical compositions comprising an anticytokyne |
EP0939121B2 (de) * | 1989-09-12 | 2007-12-26 | AHP Manufacturing B.V. | TFN-bindende Proteine |
GB9015908D0 (en) * | 1990-07-19 | 1990-09-05 | Celltech Ltd | Multivalent immunoglobulin |
EP0620739A4 (en) * | 1992-09-15 | 1997-01-15 | Immunex Corp | Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists. |
CA2147180A1 (en) * | 1992-10-15 | 1994-04-28 | Gokhan S. Hotamisligil | Treatment of insulin resistance in obesity linked type ii diabetes using antagonists to tnf-.alpha. function |
-
1995
- 1995-07-15 HU HU9700180A patent/HUT76666A/hu unknown
- 1995-07-15 WO PCT/EP1995/002788 patent/WO1996003141A1/en not_active Application Discontinuation
- 1995-07-15 BR BR9508419A patent/BR9508419A/pt not_active IP Right Cessation
- 1995-07-15 JP JP8505421A patent/JPH09508140A/ja active Pending
- 1995-07-15 AU AU31119/95A patent/AU3111995A/en not_active Abandoned
- 1995-07-15 CZ CZ97193A patent/CZ283219B6/cs not_active IP Right Cessation
- 1995-07-15 EP EP95926902A patent/EP0772449A1/en not_active Withdrawn
- 1995-07-15 PL PL95318501A patent/PL318501A1/xx unknown
- 1995-07-15 CA CA002195665A patent/CA2195665A1/en not_active Abandoned
-
1997
- 1997-01-21 FI FI970247A patent/FI970247A0/fi unknown
- 1997-01-21 NO NO970264A patent/NO970264L/no unknown
Also Published As
Publication number | Publication date |
---|---|
WO1996003141A1 (en) | 1996-02-08 |
FI970247A (fi) | 1997-01-21 |
NO970264D0 (no) | 1997-01-21 |
JPH09508140A (ja) | 1997-08-19 |
EP0772449A1 (en) | 1997-05-14 |
CZ283219B6 (cs) | 1998-02-18 |
CZ19397A3 (en) | 1997-06-11 |
PL318501A1 (en) | 1997-06-23 |
BR9508419A (pt) | 1997-11-18 |
NO970264L (no) | 1997-03-24 |
HUT76666A (en) | 1997-10-28 |
FI970247A0 (fi) | 1997-01-21 |
AU3111995A (en) | 1996-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2195665A1 (en) | Pharmaceutical compositions comprising a chimaeric tnf binding protein | |
JP6526872B2 (ja) | 関節リウマチの治療のための可溶性cd24の使用方法 | |
US20210003571A1 (en) | Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent | |
DE69633624T2 (de) | Lösliche lymphotoxin-beta -rezeptoren, antikörper gegen den lymphotoxinrezeptor und ligand-antikörper als therapeutische reagenzien in der behandlung von immunkrankheiten | |
DE69533331T2 (de) | Liganden zur induktion der antigen-spezifischen apoptose in t-zellen | |
KR20070047327A (ko) | 항-cd154 항체 | |
WO2000012130A1 (en) | Rp105 agonists and antagonists | |
EP0936923A1 (en) | SUPPRESSION OF TNF $g(a) AND IL-12 IN THERAPY | |
DE69736597T2 (de) | Gdnf rezeptor | |
US5676940A (en) | Method of reducing immunoglobulin E responses | |
ES2210551T3 (es) | Neuritina, un neurogeno. | |
DE69931944T2 (de) | Umkehr des viral-induzierten systemischen schocks und des atemnotsyndroms durch blockierung des lymphotoxin-beta- aktivierungsweges | |
US6995237B1 (en) | Preparation and composition of peptides useful for treatment of autoimmune and transplant related graft versus host conditions | |
JP4452312B2 (ja) | T細胞抗原受容体ペプチド | |
KR100622960B1 (ko) | 림프독소(lt)경로 저해제를 사용한 여포 림프종의 치료 방법 | |
EP1223958A2 (en) | Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions | |
JP2002505576A (ja) | 神経栄養因子レセプター | |
CA2456247C (en) | Use of il-18 inhibitors in hypersensitivity disorders | |
US5861164A (en) | Vaccination against diseases resulting from pathogenic responses by specific T cell populations | |
DE69637429T2 (de) | Gene, die für lymphocyte spezifischen interferon-regulationsfaktor (lsirf) polypeptide kodiert | |
EP1598370A2 (en) | Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions | |
MXPA06009446A (en) | Pharmaceutical composition for treatment of immunological disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |